Glycogen storage disease type III natural history, complications and prognosis: Difference between revisions
Line 22: | Line 22: | ||
===Complications=== | ===Complications=== | ||
*Common complications of | *Common complications of glycogen storage disease type III include:<ref name="pmid8750616">{{cite journal| author=Lee P, Burch M, Leonard JV| title=Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III. | journal=J Inherit Metab Dis | year= 1995 | volume= 18 | issue= 6 | pages= 751-2 | pmid=8750616 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8750616 }} </ref> | ||
**Left ventricular hypertrophy | **Left ventricular hypertrophy | ||
**Cardiomyopathy | **Cardiomyopathy |
Revision as of 14:47, 12 December 2017
Glycogen storage disease type III Microchapters |
Differentiating Glycogen storage disease type III from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type III natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type III natural history, complications and prognosis |
FDA on Glycogen storage disease type III natural history, complications and prognosis |
CDC on Glycogen storage disease type III natural history, complications and prognosis |
Glycogen storage disease type III natural history, complications and prognosis in the news |
Blogs on Glycogen storage disease type III natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of glycogen storage disease type III include:[1]
- Left ventricular hypertrophy
- Cardiomyopathy
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Lee P, Burch M, Leonard JV (1995). "Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III". J Inherit Metab Dis. 18 (6): 751–2. PMID 8750616.